Antagonists of group i metabotropic glutamate receptors and cortical afterdischarges in immature rats

Epilepsia

Volumn 50, Issue 9, 2009, Pages 2123-2129

  Lojková Janečková, Denisa ^a   Ng, Jessica ^a,b   Mareš, Pavel ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Anticonvulsant action; Cortical stimulation; Epileptic afterdischarges; Metabotropic glutamate receptors; Ontogeny; Rat

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; PENTETRAZOLE;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BODY MOVEMENT; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CLONIC SEIZURE; CONTROLLED STUDY; CONVULSION; DEVELOPMENTAL STAGE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ELECTRIC CURRENT; ELECTROCORTICOGRAPHY; ELECTRODE; EPILEPTIC DISCHARGE; GROUPS BY AGE; LOW DRUG DOSE; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR CORTEX;

ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; CEREBRAL CORTEX; CONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 67849110626     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02091.x     Document Type: Article

References (45)

1. Alexander GM, Godwin DW 2006) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res 71 : 1 22.
2. Anwyl R 1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev 29 : 83 120.
3. Avanzini G, de Curtis M, Marescaux C, Panzica F, Spreafico R, Vergnes M 1992) Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves. J Neural Transm Suppl 35 : 85 95.
4. Bordi F, Ugolini A 2000) Involvement of mGluR(5) in acute nociceptive transmission. Brain Res 871 : 223 233.
5. Browning RA, Nelson RA 1986) Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 93 : 546 556.
6. Chapman A 1991) Excitatory amino acid antagonists and therapy of epilepsy. In Meldrum BS (Ed) Excitatory amino acid antagonists. Blackwell, London, pp. 265 286.
7. Chapman AG, Yin PK, Yap JS, Quinn LP, Tang E, Hartus JR, Meldrum BS 1999) Anticonvulsant actions of LY367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid). Eur J Pharmacol 368 : 17 24.
8. Chapman AG, Nanan K, Williams M, Meldrum BS 2000) Anticonvulsant activity of two metabotropic glutamate group I antagoists selective for the mGluR5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl- pyridine (SIB 1893). Neuropharmacology 39 : 1567 1574.
9. Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, Rao S, Washburn M, Varney MA 2003) 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem 46 : 204 206. (Pubitemid 36078139)
10. Doherty J, Dingledine R 2002) The roles of metabotropic glutamate receptors in seizures and epilepsy. Curr Drug Targets 1 : 251 260.
11. Gasparini F, Lingenhohl G, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Unwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Veliçelebi G, Kuhn R 1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38 : 1493 1503.
12. Hauser WH, Hesdorffer DH 1990) Epilepsy: frequency, causes and consequences, Demos Press, New York.
13. Heidbreder CA, Bianchi M, Lacroix IP, Faedo S, Perdona F, Remelli R, Cavanni P, Crespi F 2003) Evidence that a metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo. Synapse 50 : 269 276.
14. Lea PM, Faden AI 2006) Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev 12 : 149 166.
15. Li X, Need AB, Baez M, Witkin JM 2006) Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J Pharmacol Exp Ther 319 : 254 259.
16. Liu X-B, Munoz A, Jones EG 1998) Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus. J Comp Neurol 395 : 450 465.
17. Lojková D, Mareš P 2005) Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats. Neuropharmacology 49 : 219 229.
18. López-Bendito G, Shigemoto R, Fairén A, Luján R 2002) Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12 : 625 638.
19. Lourenço Neto F, Schadrack J, Berthele A, Zieglgänsberger W, Tölle TR, Castro-Lopes JM 2000) Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res 854 : 93 105.
20. Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ 2001) Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci 21 : 5925 5934.
21. Marchetti C, Taccola G, Nistri A 2003) Distinct subtypes of group I metabotropic glutamate receptors on rat spinal neurons mediate complex facilitatory and inhibitory effects. Eur J Neurosci 18 : 1873 1883.
22. Mareš P, Mikulecká A 2004) MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance. Epilepsy Res 60 : 17 26.
23. Mareš P, Kubová H 2006) Electrical stimulation-induced models of seizures. In Pitkanen A, Schwartzkroin PA, Moshe SL (Eds) Models of seizures and epilepsy. Elsevier Academic Press, San Diego, pp. 153 159.
24. Mareš P, Šlamberová R 2006a) Efficacy of bretazenil against cortical epileptic afterdischarges increases during early ontogeny in rats. Pharmacol Rep 58 : 519 525.
25. B antagonist in two models of epileptic seizures in developing rats. Brain Res Bull 71 : 160 166.
26. Mareš P, Tabashidze N 2008) Contradictory effects of GABA-B receptor agonists on cortical epileptic afterdischarges in immature rats. Brain Res Bull 75 : 173 178.
27. Mareš P, Haugvicová R, Kubová H 2002) Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res 49 : 35 43.
28. Mareš P, Folbergrová J, Kubová H 2004) Excitatory aminoacids and epileptic seizures in immature brain. Physiol Res 53 (suppl 1 S115 S124.
29. Mareš P 2009) Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats. Epilepsy Res 83 : 215 223.
30. Merlin LR 2002) Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol 87 : 621 625.
31. Mikulecká A, Mareš P 2002) NMDA receptor antagonists impair motor performance in immature rats. Psychopharmacology 162 : 364 372.
32. Moldrich RX, Chapman AG, De Sarro G, Meldrum BS 2003) Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 476 : 3 16.
33. Movsesyan VA, O'Leary DM, Fan L, Bao W, Mullins PG, Knoblach SM, Faden AI 2001) mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenyIethenyl)pyridine reduce traumatic neuronal in-jury in vitro and in vivo by antagonising N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 296 : 41 47.
34. Nagaraja RY, Grecksch G, Reymann KG, Schroeder H, Becker A 2004) Group I metabotropic receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits. Naunyn Schmiedebergs Arch Pharmacol 370 : 26 34.
35. Poisik OV, Mannaioni G, Traynelis SF, Smith Y, Conn PJ 2003) Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus. J Neurosci 23 : 122 130.
36. Poisik OV, Smith Y, Conn PJ 2007) D1- and D2-like dopamine receptors regulate signalling properties of group I metabotropic glutamate receptors in the rat globus pallidus. Eur J Neurosci 26 : 852 862.
37. Racine RJ 1972) Modification of seizure activity by electrical stimulation: II. Motor seizures. Electroencephalogr Clin Neurophysiol 32 : 281 294.
38. Renaud J, Emond M, Meilleur S, Psarropoulou C, Carmant L 2002) AIDA, a class I metabotropic glutamate-receptor antagonist limits kainate-induced hippocampal dysfunction. Epilepsia 43 : 1306 1317.
39. Ritzén A, Mathiesen JM, Thomsen C 2005) Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators. Basic Clin Pharmacol Toxicol 97 : 202 213.
40. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N 1993) Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163 : 53 57.
41. Szydlowska K., Kaminska B, Baude A, Parsons CG, Danysz W 2007) Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo. Eur J Pharmacol 554 : 18 29.
42. Thomsen C, Dalby NO 1998) Role of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice. Neuropharmacology 37 : 1465 1473.
43. Thuault SJ, Davies CH, Randall AD, Collingridge GL 2002) Group I mGluRs modulate the pattern of non-synaptic epileptiform activity in the hippocampus. Neuropharmacology 41 : 141 146.
44. Werner CG, Scartabelli T, Pancani T, Landucci F, Moroni F, Pellegrini-Giampietro DE 2007) Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance. Eur J Neurosci 25 : 3597 3604.
45. Witkin JM, Baez M, Yu J, Eiler WJA II. 2008) mGlu5 receptor deletion does not confer seizure protection to mice. Life Sci 83 : 377 380.